BMAL1 and breast carcinoma: For example, Bmal1-deficient fibroblasts exhibit reduced sensitivity to DNA-damaging anticancer drugs, such as etoposide and daunorubicin, while Bmal1 knockout mutation in the breast cancer cell line MCF10A sensitizes to cisplatin-induced apoptosis36,37.